Discontinuing Glucagon-Like Peptide-1 Receptor Agonists and Body Habitus: A Systematic Review and Meta-Analysis
Su principio activo, tirzepatida, combina la accin GLP-1 con la del GIP, lo que le da un doble efecto: regula glucosa y reduce apetito, pero tambin mejora cmo el cuerpo gestiona la grasa
Daily dosing vs three times weekly dosing The question of whether you can reduce from daily to three times per week comes up frequently with sublingual GLP-1 drops
Potential side effects may include nausea, vomiting, constipation, diarrhea, upset stomach, injection site irritation, low blood sugar in certain settings, and allergic reactions
So unlike a lot of chemicals, these hormones are likely to do what they're supposed to do and not to cause too much trouble